Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 100.64 billion as of June 16, 2025. Its market cap has increased by 61.74% in one year.

Market Cap

100.64B

Enterprise Value

112.52B

Revenue

22.24B

Ranking

n/a

PE Ratio

21.80

Stock Price

110.44

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 100.64B, an increase of 72,443.06%. That is a compound annual growth rate of 21.79%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	100.64B	9.45%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	170.36B
Shell	156.00B
HSBC Holdings	150.56B
Unilever	115.47B
British American Tobacco p.l.c.	78.56B
Rolls-Royce Holdings	72.69B
Rio Tinto Group	72.66B
RELX PLC	71.43B

Market Cap Rankings